Public Market Listing
Live quotes, historical charts, and market capitalization for JW Pharmaceutical are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(7 total)
| Target & Modality | |||
|---|---|---|---|
Anagliptin(Suiny) | Phase 3 | DPP-4Small molecule | Type 2 Diabetes |
| Phase 3 | GLP-1 receptorPeptide | ObesityType 2 Diabetes | |
| Phase 3 | HIF prolyl hydroxylase (HIF-PH1/2/3)Small molecule | Chronic Kidney Disease | |
| Phase 3 | Dipeptidyl peptidase-4 (DPP-4)Small molecule | Type 2 Diabetes | |
Mitiglinide(Glufast) | Phase 3 | SUR1 (short-acting)Small molecule | Type 2 Diabetes |
LivaloVNo recent activity | Phase 1 | HMG-CoA reductase / Angiotensin II type 1 receptorSmall molecule | HypertensionAtherosclerotic Cardiovascular Disease |
| Preclinical / Unstaged | Undisclosed / early pipelineSmall molecule | Hypertension |
Discontinued programmes (1)
Development of these assets stopped. Each page states the sourced discontinuation and keeps the trials as evidence history.
Upcoming events
(3 total)
Estimated primary-completion dates from ClinicalTrials.gov and expected earnings reports. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Add these trial readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.
Regulatory and conference events
(2)
Filings, regulator decisions, scientific presentations, topline results and licensing deals, each from a dated source. When a source gives only the month, the month is shown.
Recent